Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPOTLIGHT: rFVIIa in Spot Sign Positive Intracerebral Hemorrhage
NCT01359202Phase 2Completed
- Start
- May 2011
- Primary completion
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Coagulation factor VIIa recombinant human in intracerebral hemorrhage (ICH). Started May 2011; status: completed.
02
Drugs
Coagulation factor VIIa recombinant human
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT01359202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01359202.